Rafael Beyar, MD, DSc, MPH

Commentary

Optimized Combination of Antiplatelet Treatment and Anticoagulation for Percutaneous Coronary <br />
Intervention: The Final Word is

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Luis Gruberg , MD;

The term acute coronary syndromes (ACS) comprise a continuum of diseases of various risks and severities including unstable angina pectoris, non-Q and Q-wave myocardial infarction (MI) and sudden death.1 These conditions share a similar...

The term acute coronary...

08/01/2008

Journal of Invasive Cardiology

Commentary

Coronary Bifurcation Interventions ‚Äî Stay on the Highway and Keep it Simple!

11/06/2009

Ariel Roguin , MD, PhD;

Rafael Beyar , MD, DSc, MPH;

In current interventional cardiology practice, the treatment of coronary bifurcation lesions remains among the few technically challenging fields. It is estimated that bifurcation lesions comprise 15–20% of all percutaneous coronary...

In current interventional...

11/06/2009

Journal of Invasive Cardiology

Percutaneous Coronary Interventions in Diabetic Patients: Is Complete Revascularization Important?

08/01/2008

Luis Gruberg , MD;

Ariel Roguin , MD, PhD;

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Chandrashekhar V. Patil , MD;

Michael Kapeliovich , MD;

Sirouch Petcherski , MD;

Monther Boulos , MD;

Shlomo Amikam , MD;

Shai Linn , MD;

Walter Markiewicz , MD;

Eugenia Nikolsky , MD, PhD;

ABSTRACT: Background. The long-term prognosis of diabetic patients with multivessel coronary artery disease (CAD) treated by surgical or percutaneous coronary revascularization is significantly worse as compared to non-diabetics. Lower rates...

ABSTRACT: Background. The...

08/01/2008

Journal of Invasive Cardiology

Commentary

Vascular Closure Devices: Is the Case Closed?

12/21/2010

Eugenia Nikolsky , MD, PhD;

Rafael Beyar , MD, DSc, MPH;

Vascular hemostasis is a key issue for the successful completion of either diagnostic or interventional percutaneous endovascular procedures. Traditionally, mechanical compression, either manual or using one of the commercially available...

Vascular hemostasis is a key...

12/21/2010

Journal of Invasive Cardiology

Traditional Versus Automated Injection Contrast System in Diagnostic and Percutaneous Coronary Interventional Procedures: Comp

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Shlomo Amikam , MD;

Walter Markiewicz , MD;

Eugenia Nikolsky , MD, PhD;

Monther Boulus , MD;

Ganeshkumar Anne , MD;

Akiva Huber ;

Luis Gruberg , MD;

Contrast-induced nephropathy is a frequent cause of hospital-acquired acute or chronic renal insufficiency in patients undergoing cardiac catheterization.1,2 The increasingly frequent use of contrast-enhancing imaging for both diagnosis and...

Contrast-induced nephropathy is...

08/01/2008

Journal of Invasive Cardiology

Commentary

Drug-Eluting Stents and Non-Cardiac Surgery: Learning Lessons the Hard Way

06/29/2011

Eugenia Nikolsky , MD, PhD;

Rafael Beyar , MD, DSc, MPH;

In this issue of the Journal, Bolad et al return the readers to a vital topic of optimal management for patients requiring non-cardiac surgery after treatment with percutaneous coronary intervention (PCI).1 Even though the subject has been...

In this issue of the Journal,...

06/29/2011

Journal of Invasive Cardiology

Commentary

Stenting in Patients with Multivessel Disease: The New Eon?

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Eugenia Nikolsky , MD, PhD;

Luis Gruberg , MD;

Since 1977, when Gruentzig introduced balloon angioplasty as a less invasive alternative to coronary artery bypass graft surgery, the results have steadily improved. The proportion of complex patients who undergo this procedure has...

Since 1977, when Gruentzig...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Drug-Eluting versus Bare-Metal Stents: When and for Whom?

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Eugenia Nikolsky , MD, PhD;

Percutaneous coronary intervention (PCI) is the most commonly performed treatment modality for obstructive coronary artery disease. Stents are an indispensable component of PCI, allowing substantial improvement in acute and long-term results...

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Commentary

Drug-Eluting versus Bare-Metal Stents: When and for Whom?

08/01/2008

Rafael Beyar , MD, DSc, MPH;

Eugenia Nikolsky , MD, PhD;

Percutaneous coronary...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

Five-Year Clinical Follow Up after Intracoronary Radiation for the Prevention of In-Stent Restenosis

08/01/2008

Eugenia Nikolsky , MD, PhD;

Arthur Kerner , MD;

Luis Gruberg , MD;

Mahmoud Sileiman , MD;

Monther Boulus , MD;

Robert Caiati , MD;

Doron Aronson , MD;

Sirush Petchersky , MD;

Rafael Beyar , MD, DSc, MPH;

Ehud Grenadier , MD;

Walter Markiewicz , MD;

Intracoronary radiation therapy (IRT), utilizing both gamma- and beta-emitting radiation sources, was until recently the only effective method for the prevention of recurrent in-stent restenosis (ISR) and the need for additional...

Intracoronary radiation therapy...

08/01/2008

Journal of Invasive Cardiology